drugset / Trial / NCT02662894
Fixed-dose Combination of Valsartan + Rosuvastatin Versus Their Isolated Components for Hypertension and Dyslipidemia.
RandomizedParallel-groupOpen-labelTreatment
Summary
Noninferiority trial to assess efficacy of fixed-dose combination of valsartan + rosuvastatin versus their isolated components in treatment of hypertension and dyslipidemia.
Timeline
- Start
- 2019-10
- Primary completion
- 2020-09
- Completion
- 2020-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 20 mg | Oral |
| Subject | Valsartan | Small molecule | 160 mg | Oral |
| Subject | Valsartan | Small molecule | 320 mg | Oral |